Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin

Pediatrics, pp. 1-9, 2016.

Cited by: 0|Bibtex|Views1|

Abstract:

BACKGROUND: We previously reported improved neurodevelopmental outcomes at 2 years among infants treated with the erythropoiesis-stimulating agents (ESAs) darbepoetin alfa (darbepoetin) or erythropoietin. Here we characterize 4-year outcomes. METHODS: Former preterm infants randomly assigned to receive darbepoetin (10 μg/kg, once per w...More

Code:

Data:

Your rating :
0

 

Tags
Comments